tirzepatide egfr cut off for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Tirzepatide, HFpEF, and the Kidney:

It's important to highlight that Mounjaro is not approved for weight loss, so those interested in weight management should consider options like Zepbound

Lilly is the only lawful supplier of FDA-approved tirzepatide medicinesMounjaro and Zepboundand does not provide tirzepatide (the active ingredient in Mounjaro and Zepbound) to compounding pharmacies, med-spas, wellness centers, online retailers, or other manufacturers

Secondary outcomes included changes in eGFR, body weight, waist circumference, blood pressure, and high-sensitivity C-reactive protein (hsCRP)

Biomechanics After Weight Loss Browning, R

Reference: PubMed (2022)